Board of Kabra Drugs approves change in directorate
At meeting held on 17 April 2017
The Board of Directors of Kabra Drugs at its meeting held on 17 April 2017 has taken the following decisions:1.The Board has accepted resignation of Rajendra Kumar Bordia from the Board of the Company.
2.The Board has appointed Kuldeep Kumar Ajmera, as Additional Director in the Independent non- executive category on the Board Of the Company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content